TAU’s Illana Gozes Wins Prestigious U.S. Alzheimer’s Award

Lauded research offers innovative AI method for improving treatment
02 December 2021

Tel Aviv University Prof. Illana Gozes, in collaboration with colleagues from Hong Kong, was named among the winners of the 2021 Healthy Longevity Catalyst Awards presented by the U.S. National Academy of Medicine (NAM) for their joint contribution at the vanguard of Alzheimer’s research.


Gozes, of the Sagol School of Neuroscience and the Adams Super Center for Brain Studies, won the award as part of an international team led by Prof. Victor OK Li and Dr. Jacqueline CK Lam from the University of Hong Kong (HKU) AI Lab to Advance Well-being and Society (HKU-AI WiSe). Their research offers an innovative AI-based approach to improve the process of identifying effective drug candidates for new Alzheimer’s therapies. The method evaluates how certain combinations of drug candidates respond to somatic (non-inherited, sporadic) gene mutations that accumulate with aging and affect the disease pathology. The findings lay the groundwork for novel treatments to boost longevity and quality of life for Alzheimer’s patients.


The Academy, together with seven global partners representing nearly 50 countries, conferred the award as part of the multi-year, international Healthy Longevity Global Competition for breakthrough innovations. Out of more than 1,000 candidates, about 150 prizes of $50,000 were awarded to advance novel ideas from innovators from across disciplines including medicine, technology, finance, social sciences, and more.


Gozes is an internationally acclaimed neuroscientist, biochemist and geneticist, renowned for her research toward drug development for Alzheimer's disease, schizophrenia and autism. She has won numerous awards for her work, including the RARE Champion of Hope -- Science International Prize by Global Genes.


"This is a great honor for me, and I am delighted that the international community sees fit to invest efforts in promoting solutions to diseases such as Alzheimer's," said Gozes. “I thank my colleagues from HKU-AI WiSe, the University of Hong Kong, led by Prof. Li and Dr. Lam, for our fruitful collaboration."


The achievement comes as TAU has placed research for healthy aging among its top priorities. As demographic shifts poise the elderly to start outnumbering the young by 2030, accelerated research and innovation is more crucial than ever to contribute to healthy longevity and wellbeing. Currently, more than 50 million people worldwide are believed to be living with Alzheimer's disease or other forms of dementia. While certain treatments reduce symptoms and progression, no cure exists for the disease.


The winning project team from left: Prof. Victor O.K. Li (HKU AI Lab to Advance Well-being and Society, the University of Hong Kong), Dr. Jacqueline C.K. Lam, Dr. Jocelyn Downey, Prof. Illana Gozes (Tel Aviv University), Mr. Han Yang and Mr. Tushar Kaistha. 




Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>